FDA warns puberty blocker may cause brain swelling, vision loss in children
by ALEC SCHEMMEL | The National Desk
View All Photos
A syringe used for hormone therapy. (Source: WKRC){p}{/p}

Earlier this month, the U.S. Food and Drug Administration added a warning to gonadotropin-releasing hormone (GnRH) agonists, commonly known as “puberty blockers,” indicating there were serious risks for youth who take them.


The U.S. Food and Drug Administration (FDA) identified six cases in females between the ages of 5 and 12, who were taking GnRH agonists, which presented “a plausible association between GnRH agonist use and pseudotumor cerebri.”

Load more...